StockData
ProQR Therapeutics N.V. logo

ProQR Therapeutics N.V. (PRQR) shareholders

PRQRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 12, 2026Score 7/30
$1.15−0.03 (-2.54%)

Close on Nov 17, 2026Market cap $121.17MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
57.6%
61M of 105M shares
Institutional holders
70
12 new, 11 sold out
Net institutional buying
26M
In Q2 2026
Insider trades, 12 months
5 buys · 0 sales
Net bought $1.34M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
ELI LILLY & Co21,995,88015.60%13G (passive) amendmentJun 26, 2026
Van Herk Investments THI B.V.
Joint filing with Van Herk Investments B.V. (14.60%), Van Herk Private Equity Investments B.V. (14.60%) and 6 more
15,384,25014.60%13D (active) amendmentJun 2, 2026
Adrianus van Herk
Joint filing with Van Herk Investments B.V. (10.90%), Van Herk Investments THI B.V. (10.90%) and 6 more
15,384,25010.90%13D (active) amendmentJun 26, 2026
Onroerend Goed Beheer- en Beleggingsmaatschappij A. van Herk B.V.
Joint filing with Van Herk Investments B.V. (10.90%), Van Herk Investments THI B.V. (10.90%) and 6 more
15,384,25010.90%13D (active) amendmentJul 27, 2026
Stichting Administratiekantoor Penulata
Joint filing with Van Herk Investments B.V. (14.60%), Van Herk Investments THI B.V. (14.60%) and 6 more
15,384,25014.60%13D (active) amendmentFeb 5, 2026
A. van Herk Holding B.V.
Joint filing with Van Herk Investments B.V. (13.60%), Van Herk Investments THI B.V. (13.60%) and 6 more
14,329,69013.60%13D (active) amendmentSep 29, 2025
Adage Capital Management, L.P.
Joint filing with Robert Atchinson (9.30%), Phillip Gross (9.30%)
9,602,2809.30%13G (passive)Dec 31, 2024
Aberdeen Group plc
Joint filing with abrdn Inc. (6.33%)
8,932,5076.33%13G (passive)Jun 30, 2026
Phillip Gross
Joint filing with Adage Capital Management, L.P. (7.70%), Robert Atchinson (7.70%)
8,102,0987.70%13G (passive) amendmentMar 31, 2025
Robert Atchinson
Joint filing with Adage Capital Management, L.P. (6.27%), Phillip Gross (6.27%)
6,601,9386.27%13G (passive) amendmentJun 30, 2025
Patrick Johan Hendrik Krol5,528,8625.20%13G (passive) amendmentJul 15, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of PRQRValueChange% of portfolio
Adage Capital Partners Gp, L.L.C.9,015,8978.56%$16.77M+2,762,4300.02%
abrdn plc8,932,5078.48%$16.61M+5,615,5420.02%
Affinity Asset Advisors, LLC5,543,9365.26%$10.31M+3,089,6580.47%
Privium Fund Management B.V.5,520,0245.24%$10.27M+52,8751.89%
Ikarian Capital, LLC3,425,9303.25%$6.37M+1,933,7010.69%
Woodline Partners LP3,277,1433.11%$6.10MNew0.02%
Heights Capital Management, Inc2,762,4302.62%$5.14MNew1.19%
Morgan Stanley1,767,2151.68%$3.29M+467,4400.00%
Sphera Funds Management Ltd.1,757,4581.67%$3.27MNew0.43%
Kynam Capital Management, LP1,566,3171.49%$2.91M–0.16%
DAFNA Capital Management LLC1,530,3611.45%$2.85M−37,2000.54%
Squadron Capital Management LLC1,511,4961.43%$2.81MNew0.87%
683 Capital Management, LLC1,393,0671.32%$2.59MNew0.13%
Citadel Advisors LLC1,184,3141.12%$2.20M+480,9910.00%
Platinum Investment Management Ltd1,159,4281.10%$2.16M−76,0860.53%
Two Sigma Investments, LP1,138,7151.08%$2.12M+219,8580.00%
Eversept Partners, LP1,022,2650.97%$1.90MNew0.10%
Boothbay Fund Management, LLC948,7360.90%$1.76M+593,4530.02%
Diadema Partners LP926,0160.88%$1.72M+745,9330.22%
UBS Group AG639,2430.61%$1.19M+333,9790.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 20267061M57.6%12 / 2511 / 1130M4M
Q1 20266935M33.3%10 / 1416 / 61M3M
Q4 20256537M35.3%10 / 2310 / 85M5M
Q3 20256438M35.6%8 / 1412 / 62M5M
Q2 20256241M38.5%4 / 1720 / 73M4M
Q1 20256541M39.2%7 / 1819 / 194M7M
Q4 20247744M42.2%39 / 176 / 832M4M
Q3 20244717M16.6%5 / 915 / 51M1M
Q2 20244817M16.4%3 / 418 / 31M1M
Q1 20244918M16.6%4 / 1015 / 20M1M
Q4 20234719M17.6%6 / 612 / 51M1M
Q3 20234619M17.8%4 / 810 / 90M3M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Boer Daniel Anton deChief Executive Officer, Director500,0000.47%Aug 3, 2026
Gerardus Johannes PlatenburgChief Scientific Officer, Director824,3880.78%Mar 18, 2026
Dennis HomChief Financial Officer––Mar 18, 2026
Bart FiliusDirector300,0000.28%Jul 21, 2026
Gylvin Lykke HinschDirector––Jun 30, 2026
Alison Frances LawtonDirector––Mar 18, 2026
Martin Alexander MaierDirector––Mar 18, 2026
Theresa HeggieDirector43,6230.04%Mar 18, 2026
Domenico ValerioDirector725,6920.69%Mar 18, 2026
Begona Carreno-GomezDirector––Mar 18, 2026
James Samuel ShannonDirector61,5380.06%Mar 18, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Boer Daniel Anton de
Chief Executive Officer, Director
Jul 31, 2026Buy+200,000$1.77$354.00K500,000
Bart Filius
Director
Jul 17, 2026Buy+150,000$1.72$258.00K300,000
Boer Daniel Anton de
Chief Executive Officer, Director
Jul 9, 2026Buy+150,000$1.74$261.00K300,000
Boer Daniel Anton de
Chief Executive Officer, Director
Jul 7, 2026Buy+150,000$1.59$238.50K150,000
Bart Filius
Director
Jun 26, 2026Buy+150,000$1.54$231.00K150,000

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
3M shares short
Days to cover
2.9
At 1M shares a day
Change since last report
-0.7%
From 3M shares
Short volume, 20 days
51.8%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of ProQR Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 10,723 shares on Sep 17, 2026 over the last 90 days.

See a number that looks wrong?